Dr Ben Taylor-Davies reviews the evolution, mechanisms and practical use of CaHA-based injectables in contemporary regenerative aesthetics
Regenerative aesthetics has emerged as one of the defining trends within contemporary medical aesthetics. It reflects a broader shift away from simply replacing lost volume toward improving tissue quality, structural support and long-term skin health.¹ Increasingly, patients seek treatments capable of delivering natural-looking rejuvenation whilst also supporting the biological function and integrity of ageing tissues. Within this evolving landscape, biostimulatory injectables have become central to many treatment strategies, offering clinicians the ability to combine immediate aesthetic correction with longer-term tissue remodelling.
Amongst these agents, calcium hydroxylapatite (CaHA) occupies a unique position due to its extensive clinical history, favourable safety profile and dual mechanism of action.² Although widely recognised within medical aesthetics as a volumising and…
